---
title: "MOTS-c"
slug: "mots-c"
type: "compound"
category: "Longevity"
url: "https://peptidesciencethailand.com/compounds/mots-c"
description: "A mitochondrial-derived peptide that activates AMPK, sometimes called an exercise mimetic. Covers metabolic research, energy pathways, and protocol details."
---
# MOTS-c

*Mitochondrial-Derived Peptide, AMPK Activation for Metabolic Optimization*

**Category:** Longevity  
**Format:** Lyophilized Vial  
**Amount:** 10mg  
**Purity:** >99.2% (HPLC)

## Overview

MOTS-c (Mitochondrial Open Reading Frame of the Twelve S rRNA-c) is a 16-amino acid peptide encoded within the mitochondrial genome, specifically within the 12S ribosomal RNA gene. Discovered in 2015 by Dr. Changhan David Lee and colleagues at the University of Southern California, MOTS-c represents a groundbreaking class of compounds known as mitochondrial-derived peptides (MDPs). Its discovery fundamentally changed the understanding of mitochondria from simple energy-producing organelles to active signaling entities that communicate with the nuclear genome and influence whole-body metabolic regulation.

MOTS-c's primary mechanism of action involves activation of AMP-activated protein kinase (AMPK), the master metabolic sensor and regulator in mammalian cells. MOTS-c activates AMPK through an indirect pathway: it inhibits the folate cycle, specifically targeting the enzyme methylenetetrahydrofolate dehydrogenase (MTHFD). This inhibition reduces de novo purine biosynthesis, leading to accumulation of the metabolic intermediate AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), which is an endogenous AMPK activator. This elegant indirect mechanism results in sustained AMPK activation that mimics many of the metabolic benefits of exercise.

AMPK activation by MOTS-c triggers a cascade of metabolic effects. It enhances glucose uptake into skeletal muscle through GLUT4 transporter translocation, improving insulin sensitivity independently of insulin signaling. AMPK also promotes mitochondrial biogenesis through PGC-1α activation, increasing the number and efficiency of mitochondria within cells. Additionally, AMPK activation shifts cellular energy metabolism toward fatty acid oxidation, promoting the use of stored fat as fuel.

The landmark study published in Cell Metabolism in 2015 demonstrated that MOTS-c administration in mice prevented age-dependent and high-fat-diet-induced insulin resistance, reduced obesity, and improved overall metabolic homeostasis. notably, MOTS-c was shown to have exercise-mimetic properties, mice receiving MOTS-c showed improved exercise capacity and metabolic profiles similar to those achieved through regular physical activity.

Subsequent research has revealed that MOTS-c levels decline with age, paralleling the age-related decline in metabolic function and exercise capacity. Studies in human populations have found that certain genetic variants in the MOTS-c sequence are associated with extended longevity, suggesting an evolutionary role in metabolic aging regulation. Japanese centenarian populations, for example, show higher prevalence of specific MOTS-c variants associated with enhanced metabolic function.

MOTS-c also demonstrates unique nuclear translocation properties. Under metabolic stress conditions, MOTS-c translocates from the cytoplasm to the cell nucleus, where it regulates gene expression through interaction with antioxidant response elements (ARE). This nuclear activity connects mitochondrial signaling to nuclear gene expression, enabling a coordinated cellular stress response that enhances metabolic resilience.

specialist oversight is essential for MOTS-c protocols because its direct effects on glucose metabolism and insulin sensitivity can interact with diabetes medications, and its influence on metabolic pathways requires monitoring through regular blood work to ensure optimal and safe dosing.

## Mechanism of Action

### Step 1: Folate Cycle Inhibition

MOTS-c inhibits MTHFD (methylenetetrahydrofolate dehydrogenase) in the folate cycle, reducing de novo purine biosynthesis and leading to accumulation of the metabolic intermediate AICAR.

### Step 2: AMPK Activation

Accumulated AICAR activates AMP-activated protein kinase (AMPK), the master metabolic sensor. This indirect activation mechanism produces sustained AMPK signaling that mimics the metabolic effects of exercise.

### Step 3: Enhanced Glucose Uptake & Insulin Sensitivity

AMPK activation promotes GLUT4 transporter translocation to cell membranes in skeletal muscle, increasing glucose uptake independently of insulin signaling and improving insulin sensitivity.

### Step 4: Mitochondrial Biogenesis via PGC-1α

AMPK activates PGC-1α (peroxisome proliferator-activated receptor gamma coactivator 1-alpha), stimulating the generation of new mitochondria and improving cellular energy production capacity.

### Step 5: Nuclear Translocation & Gene Regulation

Under metabolic stress, MOTS-c translocates to the nucleus and interacts with antioxidant response elements (ARE), coordinating gene expression that enhances metabolic resilience and cellular stress resistance.

## Researched Benefits

### Metabolic Optimization

Through AMPK activation, MOTS-c enhances glucose metabolism, promotes fatty acid oxidation, and improves insulin sensitivity. These exercise-mimetic metabolic effects have been demonstrated in preclinical studies to prevent diet-induced obesity and age-related metabolic dysfunction.

### Exercise Capacity Enhancement

Research shows MOTS-c improves exercise performance and endurance capacity through increased mitochondrial biogenesis and enhanced cellular energy metabolism. Its effects parallel those achieved through regular physical activity, making it of particular interest for metabolic aging research.

### Longevity-Associated Signaling

MOTS-c levels decline with age, and certain MOTS-c genetic variants are associated with extended longevity in human populations. Its ability to restore youthful metabolic signaling patterns positions it as a key molecule in longevity and healthspan research.

### Mitochondrial Function Support

Through PGC-1α activation, MOTS-c stimulates mitochondrial biogenesis, the creation of new mitochondria, improving overall cellular energy production. This addresses the fundamental role of mitochondrial decline in aging and metabolic disease.

## Dosage & Administration

| Parameter | Detail |
| --- | --- |
| Protocol | 5-10mg administered subcutaneously 3 times weekly |
| Route | Subcutaneous injection |
| Duration | 4-8 weeks per cycle |
| Cycle Notes | Protocols typically run 4-8 weeks with 4-week rest periods between cycles. Some research protocols use 5mg daily for shorter 2-week intensive cycles. Effects on insulin sensitivity may be measurable within 2-3 weeks. |
| Reconstitution | Reconstitute with bacteriostatic water. Using 10mg with 2mL yields 5000mcg/mL. Store reconstituted solution at 2-8°C and use within 21 days. |

> **Specialist note:** MOTS-c directly affects glucose metabolism and insulin sensitivity. A specialist would order baseline fasting glucose, fasting insulin, HbA1c, and lipid panel before initiating the protocol, with follow-up testing to monitor metabolic response and adjust dosing accordingly.

## Compound Reference Data

| Property | Value |
| --- | --- |
| Format | Lyophilized Powder |
| Amount | 10mg per vial |
| Purity | >99.2% |
| Purity Method | HPLC (High-Performance Liquid Chromatography) |
| Sequence | Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg |
| Molecular Weight | 2174.64 g/mol |
| Storage | Store lyophilized powder at -20°C. Reconstituted solution at 2-8°C. Protect from light and moisture. |
| Appearance | White to off-white lyophilized powder |

## Medical Guidance

MOTS-c directly modulates glucose metabolism and insulin sensitivity through AMPK activation, meaning it can significantly interact with diabetes medications including metformin (which shares the AMPK activation pathway), sulfonylureas, and insulin. Patients with metabolic disorders require careful specialist monitoring with regular blood glucose and HbA1c testing throughout the protocol to prevent hypoglycemic events.

## Frequently Asked Questions

### What is MOTS-c and why is it significant?

MOTS-c is a 16-amino acid peptide encoded within the mitochondrial genome, discovered in 2015 at the University of Southern California. It is significant because it established mitochondria as active signaling organelles that influence whole-body metabolism, not just energy producers. MOTS-c activates AMPK, the master metabolic regulator, producing exercise-mimetic effects on glucose metabolism, fat oxidation, and mitochondrial biogenesis.

### What medical guidance applies to MOTS-c?

MOTS-c is a compound studied in clinical research that should only be used under qualified medical supervision. Because it directly affects glucose metabolism and insulin sensitivity, specialist supervision with baseline and ongoing blood work is essential. A specialist would monitor fasting glucose, insulin levels, and HbA1c to ensure the protocol is safe and effective for individual metabolic profile.

### How does MOTS-c mimic exercise?

MOTS-c activates AMPK through folate cycle inhibition, triggering the same metabolic cascade that exercise induces, enhanced glucose uptake, increased fatty acid oxidation, mitochondrial biogenesis, and improved insulin sensitivity. Preclinical studies showed mice receiving MOTS-c exhibited improved exercise capacity and metabolic profiles similar to exercised animals. However, MOTS-c is not a replacement for physical activity, which provides additional benefits.

### Is MOTS-c connected to aging?

Research shows MOTS-c levels decline with age, paralleling age-related metabolic dysfunction. Certain MOTS-c genetic variants are associated with extended longevity in human populations, including Japanese centenarians. By restoring AMPK activation and metabolic signaling that diminishes with age, MOTS-c represents a promising area of healthspan and longevity research.

### Can MOTS-c be used alongside exercise?

Research protocols often investigate MOTS-c in conjunction with exercise programs, as their AMPK activation mechanisms may be synergistic. MOTS-c is not intended to replace exercise but may complement physical activity by enhancing metabolic adaptations. A your specialist will design a protocol that integrates MOTS-c with your activity level and metabolic goals.

## Related Compounds

- /compounds/aod-9604
- /compounds/epithalon
- /compounds/cjc-1295-ipamorelin

## Comparisons

- /compare/aod-9604-vs-mots-c